Skip to main content
. 2018 Jan 31;187(7):1520–1529. doi: 10.1093/aje/kwx386

Table 2.

Estimated Coefficients for Time to Total Cardiovascular Disease From a Joint Model With a Quadratic Longitudinal Hemoglobin A1c Submodel and a Cox Survival Submodel, Pittsburgh Epidemiology of Diabetes Complications Study, 1986–2014

Submodel and Covariate Estimatea 95% CI
Model 1b
Longitudinal HbA1c level
 Intercept 8.88 8.74, 8.98
 Time, years 0.05 0.02, 0.08
 Time2 −0.005 −0.007, −0.004
Cox survival
 Association parameter 0.26 0.07, 0.40
Model 2c
Longitudinal HbA1c level
 Intercept 8.09 7.70, 8.43
 Time, years 0.05 0.02, 0.08
 Time2 −0.005 −0.007, −0.003
 Type 1 diabetes duration −0.03 −0.05, −0.02
 Non-HDL cholesterol level 0.01 0.008, 0.01
 Hypertension −0.32 −0.67, 0.009
Cox survival
 Type 1 diabetes duration 0.07 0.05, 0.09
 Non-HDL cholesterol level 0.01 0.005, 0.01
 Hypertension 0.56 0.16, 0.93
 ln(AER) 0.16 0.07, 0.22
 White blood cell count 0.09 0.03, 0.17
 Association parameter 0.23 0.07, 0.37
Model 3d
Longitudinal HbA1c level
 Intercept 7.82 7.39, 8.29
 Time, years 0.05 0.02, 0.08
 Time2 −0.006 −0.008, −0.004
 Type 1 diabetes duration −0.04 −0.05, −0.02
 Non-HDL cholesterol level 0.01 0.006, 0.013
 ln(AER) 0.11 0.04, 0.17
Cox survival
 Type 1 diabetes duration 0.08 0.05, 0.10
 Non-HDL cholesterol level 0.01 0.006, 0.01
 ln(AER) 0.24 0.17, 0.33
 Association parameter 0.12 −0.006, 0.28

Abbreviations: AER, albumin excretion rate; CI, confidence interval; CVD, cardiovascular disease; HbA1c, hemoglobin A1c; HDL, high-density lipoprotein.

a Per unit (see Table 1).

b Unadjusted.

c Adjusted for baseline levels of CVD risk factors.

d Adjusted for updated mean levels of CVD risk factors.